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Abstract
Background:  Massive gene expression changes in different cellular states measured by
microarrays, in fact, reflect just an "echo" of real molecular processes in the cells. Transcription
factors constitute a class of the regulatory molecules that typically require posttranscriptional
modifications or ligand binding in order to exert their function. Therefore, such important
functional changes of transcription factors are not directly visible in the microarray experiments.
Results: We developed a novel approach to find key transcription factors that may explain
concerted expression changes of specific components of the signal transduction network. The
approach aims at revealing evidence of positive feedback loops in the signal transduction circuits
through activation of pathway-specific transcription factors. We demonstrate that promoters of
genes encoding components of many known signal transduction pathways are enriched by binding
sites of those transcription factors that are endpoints of the considered pathways. Application of
the approach to the microarray gene expression data on TNF-alpha stimulated primary human
endothelial cells helped to reveal novel key transcription factors potentially involved in the
regulation of the signal transduction pathways of the cells.
Conclusion:  We developed a novel computational approach for revealing key transcription
factors by knowledge-based analysis of gene expression data with the help of databases on gene
regulatory networks (TRANSFAC®  and TRANSPATH®). The corresponding software and
databases are available at http://www.gene-regulation.com.
Background
New high-throughput methods, such as microarrays,
allow generation of massive amounts of molecular bio-
logical data. These, mainly phenomenological, data are
often difficult to relate with the activation/inhibition of
particular signal transduction pathways and/or transcrip-
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tional regulators. Gene expression changes in different
cellular states measured by microarrays, in fact, reflect just
an "echo" of real molecular processes in the cells. A way
to facilitate data interpretation is to construct gene regula-
tory networks that include signal transduction mediators,
transcriptional regulators and target genes. This is a com-
plex task, not only because of the huge number of mole-
cules involved, but also because of variations across
tissues, developmental stages and physiological condi-
tions. However, these networks hold the key to the under-
standing of the regulatory processes within a cell and,
thus, to the majority of life processes in general.
Changes of expression of genes encoding transcription
factors (TFs), a class of key regulatory molecules, are often
hard to reveal to be significantly up- or downregulated in
microarray experiments since their expression changes are
small and their activity is mainly regulated on the post-
transcriptional level. Analysis of promoters of co-
expressed genes can provide one source of evidences on
involvement of certain TFs in the regulation of the genes.
Several computational approaches have been developed
in the past few years in order to reveal potential binding
sites in the promoter regions of co-expressed genes. They
applied various techniques ranging between simple pat-
tern search and complex models such as HMMs (Hidden
Markov Models). The most widely used method is based
on positional weight matrices (PWMs) that are con-
structed from collections of known binding sites for given
TF or TF family. One of the largest collections of TF bind-
ing sites (TFBS) and corresponding PWMs is the TRANS-
FAC®  database [1]. The PWM approach was applied
intensively in the last years for the analysis of regulatory
regions of many different functional classes of genes, for
instance, globin genes [2], muscle- and liver-specific genes
[3,4], and cell cycle-dependent genes [5]. In recent
approaches, in order to improve the site prediction qual-
ity, different authors have searched for combinations of
TFBS – cis-regulatory modules [6-10] and have applied
comparative genomics approaches [11-13]. Despite these
efforts, understanding the full complexity of the gene reg-
ulatory regions remains a great challenge and it is still
rather problematic to identify transcription factors
involved in the regulation of genes under any particular
cellular condition based on the promoter analysis alone.
Another source of evidences on the key role of transcrip-
tion factors in regulating cellular regulatory processes
comes from analysis of signal transduction pathways.
Multiple signal transduction pathways of a cell transduce
extracellular signals from receptors at the cellular mem-
brane to the transcription factors in the nucleus where
they regulate the transcription of genes. There are several
databases that collect information about signal transduc-
tion pathways in different cells. Among them, the TRANS-
PATH® database [14] stores a large body of information on
signaling pathways allowing computational search
through the graph of signaling reactions. One aim of such
searches is to find the key transcription factors that medi-
ate the concerted changes in expression of specific compo-
nents of the signal transduction network.
In this paper we report an attempt to integrate the two
complementary approaches for identification of key TFs:
1) analysis of promoters of co-expressed genes and 2)
analysis of networks of the differentially expressed com-
ponents of the signal transduction pathways. We have
developed two computational tools: F-Match™ for reveal-
ing over- and underrepresented sites of promoters and
ArrayAnalyzer™ for identification of key nodes in signal
transduction networks. The developed integrated
approach aims to reveal multiple evidences of positive
feedback loops in signal transduction circuits through
activation of pathway-specific transcription factors.
We demonstrated that promoters of genes encoding com-
ponents of many known signal transduction pathways are
enriched by binding sites of those transcription factors
that are end-points of the considered pathways. Applica-
tion of the approach to the microarray gene expression
data on TNF-alpha stimulated primary human endothe-
lial cells [15] helped to reveal novel key transcription fac-
tors that are potentially involved in the regulation of the
signal transduction pathways of these cells.
Results
TFBS in promoters of genes belonging to the same 
pathway
In order to evaluate the approach we applied the pro-
moter analysis algorithm (see Methods) to the promoters
of genes encoding various known signal transduction
pathways. Promoter sequences were extracted from the
TRANSPRO® database [16]. We were also testing a hypo-
thesis that genes encoding components of the same sign-
aling pathway are co-regulated by the "target transcription
factors", i.e. TFs that receive the signal through the path-
way in focus and, through that, provide multiple positive
feedback loops in the pathway. We made this analysis for
pathways and chains collected in the TRANSPATH® data-
base. Chains represent experimentally proven sequences
of reactions and are utilized in the pathway search algo-
rithm using nonlinear cost function (Figure 1).
We applied the Match™ tool [17] with default parameters
(vertebrate matrices, minSUM cut-offs) and searched for
potential TFBS in promoters of the genes encoding com-
ponents of signal transduction pathways (see Methods).
After that, we applied F-Match to compare site frequency
in promoters of each pathway compared to the promoters
of all other pathways. We found overrepresented sites forBMC Bioinformatics 2006, 7(Suppl 2):S13
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target TFs in 13 pathways and 23 chains (see Table 1). In
the cases where the chains constitute a part of the same
pathway, the sites were grouped together. Only 7 path-
ways and 2 chains exhibited underrepresented sites for
their target TFs.
We exemplarily show the results for two pathways (see
Figure 2 and Figure 3). Sites for AP-1 factors have been
found being over-represented in promoters of genes
encoding components of JNK pathway. AP-1 sites were
found in promoters of several genes encoding different
variants of JNK kinases as well as other molecules
upstream and downstream in the pathway leading to the
activation and repression of the AP-1 transcription factors
(see Figure 2). Such complex organization of the regula-
tory circuits clearly provides mechanisms for the autoreg-
ulation of the pathway. Evidence for direct autoregulation
was found also for the pathways and networks activating
the following TFs: p53, HIF1-alpha, p300, SRF, c-jun, NF-
AT and DP1.
In the case of T-cell antigen receptor pathway sites for
transcription factors Ets/Elk-1 are overrepresented in the
promoters of the genes of this pathway. Most of the hits
are located in the "upper" part of the pathway, e.g. mole-
cules located in the pathway several steps upstream from
the target transcription factors at the "bottom" (see Figure
3). We speculate that such organization of feedback loops
from regulated TFs to the topmost parts of the pathway
can provide optimal autoregulation, and enhances the
specificity of the transduced signal.
In the extreme case of the prolactin pathway, more than
half of the genes in the pathway are probably regulated by
the target TF FKHRL, including both the membrane recep-
tor molecule and the target TFs STAT5A and STAT5B (see
Figure 4).
Since the PWMs used for identification of TFBS are rela-
tively short, the chance that they can match with any DNA
sequence is very high. The essence of our method is there-
fore to estimate the statistical significance of over- or
under-representation of the number of matches in a given
set of promoters (see Method section) as an indicator of
potential functional involvement of TFs in the regulation
of the corresponding genes. Here, we did an evaluation of
the statistical significance of overrepresentation of Elk-1
sites found in the promoters of T-cell antigen receptor
pathway. Two datasets were built collecting human pro-
moter sequences at random from the TRANSPRO® data-
base, one with the same number as in the T-cell antigen
receptor pathway (65 promoters), and another with as
many promoters as in the control set (990 promoters).
Elk-1 sites were predicted in both sets using the Match™
program, and their frequencies compared using F-Match.
This simulation experiment was repeated 100 times, and
a distribution of the ratio of Elk-1 site frequency in the
query vs. control set was generated (see Figure 5). The
average ratio of this random promoters distribution is
1.28 with a standard deviation of 0.21. Whereas, the ratio
observed in the real set of promoters of T-cell antigen
receptor pathway is 2.1 (we found Elk-1 sites in 13 pro-
moters, but random expectation is 6.2 promoters), which
is 3.9 SD units away from the random expectation (see
Figure 5).
Identification of key node TFs in the TRANSPATH® 
pathways
To evaluate whether the "pathway persistence" parameter
h can help in identifying key TFs, we applied the Pathway
Persistence algorithm described in the Methods section to
the T-cell antigen receptor pathway as it is presented in
the TRANSPATH® database (see Figure 3). As it can be seen
from the diagram, 6 target transcription factors of this
pathway are AP-1 (c-Jun), NF-AT, NF-kappaB (het-
erodimer of p50 and RelA), IkappaB and Elk-1. Out of 51
molecules belonging to this pathway we took 13 mole-
cules whose gene promoters contain the Elk-1 binding
Cost transformation function Figure 1
Cost transformation function. Different variants of the 
cost transformation function f(CPij) for different values of h – 
"pathway persistence" (marked by different functions x1-h, h 
= 0.0, 0.2,...1.0). Under h = 1 the effect is maximal, since the 
cost of adding a new path that belongs to a known pathway 
does not depend on the length of the path and is always 
equal to 1.0. Under these conditions the search will stay 
within known pathways only.BMC Bioinformatics 2006, 7(Suppl 2):S13
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sites (see Figure 3, molecules marked by red rectangles)
identified at the previous step of analysis. We applied the
key node search algorithm starting from these 13 mole-
cules and searched downstream with parameters of the
search: dmax = 4, α = (1/2)12 ; h = 0.9. The 7 top scoring
transcription factors were: (E2F, IkappaB, NF-kappaB,
PPAR-gamma, c-Jun, Egr-1, RXR-alpha). As one can see,
NF-kappaB and components of AP-1 were among the top
hits. Figure 6 shows the automatically generated output
for the search of key TFs of the pathway.
Table 1: Over and under-represented sites in pathways. Pathways in which over- and under-represented sites were identified for 
"target" transcription factors – TFs that receive the signal through the pathway in focus. Corresponding PWMs are shown.
Pathway in TRANSPATH® TF (family) TRANSFAC® PWM acc p-value
Overrepresented sites in pathways
mTOR --> S6& eIF-4E STAT M00777 9.51E-003
MHC class II -> NF-AT NF-AT M00935 1.92E-004
IFNgamma -> STAT1alpha STAT M00777 6.27E-003
BCR -> c-Jun AP-1 M00517 8.91E-003
BCR -MLK3-> c-Jun AP-1 M00517 6.61E-003
TNF-alpha -> NFkappaB NF-kappaB M00774 9.86E-003
VEGF-A -> NF-ATc NF-AT M00935 7.31E-003
15d-PGJ2 -> PPAR-gamma p300 M00033 7.16E-003
G1 phase (Cdk4) E2F M00738 9.53E-004
S phase (Cdk2) E2F M00738 6.96E-006
IL-1beta -> c-Jun AP-1 M00517 2.89E-003
MKK6 -> p53 p53 M00761 8.64E-003
MKP-5 -/p53; MKK4 -> p53 p53 M00761 7.47E-003
Caspase-3 -/p53 p53 M00761 9.81E-003
p53 pathway AhR M00976 7.59E-003
HIF-1alpha pathway AhR M00976 2.34E-003
IL-1 pathway AP-1 M00517 6.57E-003
E2F network E2F M00738 7.73E-006
T-cell antigen receptor pathway Ets/Elk-1 M00971 7.44E-005
TLR4 pathway p300 M00033 4.29E-003
stress-associated pathways Ebox; AP-1 M01034; M00517 5.96E-03; 1.26E-03
EDAR pathway NF-kappaB M00774 8.90E-004
wnt pathway Ets M00971 7.10E-003
TNF-alpha pathway NF-kappaB M00774 9.03E-003
EDA-A2 -TRAF3-> NF-kappaB NF-kappaB M00774 2.31E-004
EDA-A1 -> NF-kappaB NF-kappaB M00774 2.31E-004
dsRNA -> IRF-7:IRF-3:CBP:p300 p300; IRF M00033; M00972 6.90E-03; 2.30E-03
TLR3 pathway NF-kappaB M00774 5.27E-004
dsRNA -> p50:RelA NF-kappaB M00774 1.35E-003
LPS -> IRF-3:IRF-7:CBP:p300 p300 M00033 4.86E-004
p38 pathway STAT; Ebox; CREB/ATF M00777; M01034; M00981 5.88E-04; 5.14E-03;2.33E-03
JNK pathway AP-1 M00517 9.24E-003
p38alpha -> MITF Ebox M01034 9.11E-003
Fas -/SRF SRF M01007 6.57E-004
PRL pathway STAT; FOX M00777; M00809 7.43E-03;6.85E-03
PRL -PI3K-> AKT FOX M00809 1.97E-005
Underrepresented sites in pathways
Rac1 -> c-Jun & Elk-1 AP-1;Ets M00172; M00971 4.92E-03;3.55E-03
insulin -> AKT-1 pathway CREB M00917 6.83E-003
EGF pathway AP-1 M00926 3.03E-003
insulin pathway CREB M00917 3.45E-003
Rac1 pathway AP-1; Ets M00172; M00971 8.14E-03; 7.46E-03
stress-associated pathways Ets M00971 8.44E-003
p38 pathway STAT M00777 1.70E-005
E1 -PIRH2-/p53 p53 M00761 6.57E-003
hypoxia pathways p300 M00033 6.45E-003BMC Bioinformatics 2006, 7(Suppl 2):S13
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In order to evaluate the Pathway Persistence algorithm we
made a series of random simulation experiments of the
pathways analysis varying the parameters dmax (3, 4) and
h (0.0, 0.6, 0.9, 1.0). For each pair of dmax and h, we ran-
domly selected 10-times 13 molecules belonging to the T-
cell antigen receptor pathway and performed the down-
stream search for the reachable TFs. We computed an aver-
age sensitivity (Se) and specificity (Sp) of the search by
counting the average number of true target TFs (N) that
were reached in such downstream search (out of the max-
imal number Nmax = 6), and by counting the average
number of other TFs (M) that were also reached in the
same search. Then:
The results of the simulation experiments are shown on
Figure 7. One can see that the use of the high values of per-
sistence parameter h  allows reaching sensitivity levels
above 50% without significant decrease of specificity.
Analysis of TNF-alpha gene expression data
We applied the F-Match method (see Methods) to analyze
promoters of differentially expressed genes in primary
human endothelial cells upon TNF-alpha stimulation
[15]. We compared promoters of genes induced or
repressed by at least a factor of 2 (fold change, FC > 2.0)
with the promoters of genes whose expression did not
change upon this treatment. In this analysis, we were able
to identify several PWMs whose hits are significantly over-
represented or under-represented in the promoters in
focus (see Table 2). We also compared results of identifi-
cation of over- and under-represented sites taking differ- Se
N
N
Sp
N
NM
=×
+ ()
×
max
%; %. 100 100  
JNK pathway Figure 2
JNK pathway. With the red rectangle we marked molecules in whose gene promoters we can identify AP-1 sites – sites for 
the "target" TFs of the pathway. As one can see, such TF sites can provide fine regulation of the pathway activity through 
numerous feedback loops.BMC Bioinformatics 2006, 7(Suppl 2):S13
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ent cut-offs of the expression fold change (FC>2.5 and FC
> 3.0, see Table 2). We observed that most of the matrices
identified at the FC cut-off 2.0, were also identified under
the higher cut-offs and often the over-representation ratio
was increasing, which clearly indicates the correlation
between the gene expression change and the frequency of
the corresponding sites in promoters. Some matrices have
disappeared from the list of the significantly over- or
under-represented sites (e.g., V$IRF_Q6 and V$MAZ_Q6)
and several new matrices have appeared under the higher
FC cut-offs (V$TBX5_02, V$HNF1_Q6, V$HFH3_01,
V$HNF3B_01, V$CEBPGAMMA_Q6). Such matrices
seem to be specific for a subgroup of promoters of the dif-
ferentially expressed genes. We focus our further attention
on the matrices that were identified under several FC cut-
offs with increased stringency.
At the second step of the analysis we mapped all differen-
tially expressed genes (with expression change higher than
2 times) onto the TRANSPATH® database and extracted
129 signaling molecules (44 up-regulated and 85 down-
regulated). Mapped molecules include all components of
signaling pathways, such as receptors, their ligands, adap-
tor proteins, kinases of various levels as well as TFs. We
applied the pathway analysis algorithm described in the
Method section (downstream search with parameters:
dmax = 4, α = (1/2)12; h = 0.9) and obtained a list of key
transcription factors (see Table 3) characterized with the
maximal score si.
By comparison of the data in the Table 2 and Table 3 we
can reveal TFs most probably involved in regulation of dif-
ferential gene expression upon TNF-alpha stimulation.
T-cell antigen receptor pathway Figure 3
T-cell antigen receptor pathway. Sites for Elk-1 factor are overrepresented in the promoters of the genes from this path-
way. Most of the hits are located at the upper part of the pathway suggesting the numerous feedback loops in the pathway.
NF-AT
c-Jun Elk-1
NF-κ κ κ κB NF-AT
c-Jun Elk-1
NF-κ κ κ κB NF-AT
c-Jun Elk-1
NF-κ κ κ κBBMC Bioinformatics 2006, 7(Suppl 2):S13
Page 7 of 13
(page number not for citation purposes)
Among them are, e.g., NF-kappaB (and its inhibitor, Ikap-
paB) and the components of AP-1 (c-Jun and c-Fos), the
known targets of TNF signaling. It is interesting to observe
that expression of genes encoding these two TFs has been
changed in this experiment. For other factors such as
FOXO, CREB, Elk-1 (ETS-domain), and E2F any signifi-
cant change of their expression was not observed, but fol-
lowing the two independent sources of evidences,
promoter analysis and pathway analysis, we conclude that
they may play an important role in the regulation of gene
expression in the considered system.
Discussion
The approach demonstrated here allows identifying key
TFs involved in the regulation of signaling pathways in the
cell. The approach combines two algorithms, one is based
on the analysis of promoter sequences and another on the
analysis of the signal transduction pathway connectivity
graph. As we demonstrated here, these two independent
algorithms can often produce rather complementary or
even similar results, pointing to the most important TFs
involved in the regulation of the considered molecular
processes.
The complementarity of the results of these two algo-
rithms may suggest interesting dynamics of the consid-
ered pathways such as for the T-cell antigen receptor
pathway analyzed above. First, we found an overrepresen-
tation of sites for the ETS domain factor Elk-1 in the pro-
moters of genes belonging to the pathway. Next, starting
from these genes and searching downstream in the signal
transduction network we identified other target TFs: NF-
kappaB, AP-1 and NF-AT. So, we can speculate, that first
signals coming through this pathway activate the Elk-1
Prolactin pathway Figure 4
Prolactin pathway. Numerous sites for the "target" transcription factor FKHRL1 can be found in promoters of many genes 
encoding components of this pathway.BMC Bioinformatics 2006, 7(Suppl 2):S13
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factors, which in turn activates expression of many genes
encoding components of the same pathway therefore
enhancing the signal flow through this pathway. The
amplified signals then activate other target transcription
factors switching on the appropriate response in the cell.
A systematic analysis of many pathways reveals that sites
for a total of 16 different TFs are overrepresented in the 36
pathways and chains, implying that different pathways
share the same target TFs. We think that the fine-tune reg-
ulation of genes in overlapping or interconnected path-
ways might be achieved through the cooperative
simultaneous regulation of many TFs, suggesting that a
composite module analysis will further explain the differ-
ential regulation of these intersecting pathways.
Conclusion
We developed a novel computational approach for reveal-
ing key transcription factors by knowledge-based analysis
of gene expression data with the help of databases on gene
transcription regulation and signal transduction net-
works, TRANSFAC® and TRANSPATH®. We demonstrated
that promoters of genes encoding components of many
known signal transduction pathways are enriched by
binding sites for transcription factors that are endpoints of
the considered pathways. The corresponding software and
databases are available at http://www.gene-regula
tion.com.
Methods
Microarray data
We have analyzed microarray gene expression data on
TNF-alpha stimulation of primary human endothelial
cells (HUVEC) [15]. Data have been taken from GEO
(GSE2639). Gene expression profiles were measured in
HUVEC stimulated for 5 hours with TNF and in untreated
HUVEC using the Affymetrix®  GeneChip®  Human
Genome U133A array [15]. Four biological replicates were
used for each condition. We applied the criteria of an at
least 2.0-fold change in gene expression levels and p-value
revealed by t-test of less than 0.05. Based on these criteria,
the expression of 121 transcripts was increased after TNF-
alpha treatment and 214 transcripts showed decreased
expression.
Promoter sequences
Promoter sequences were taken from TRANSPRO® [16], a
database based on the international Genomic Sequence
Builds for H. sapiens, M. musculus and R. norvegicus. We
have collected information about TSSs from several data-
bases, EPD [18], dbTSS [19] and Ensembl [20]. Collected
TSSs are frequently not located in tight clusters, but wide-
spread throughout the sequence. An algorithm applying a
set of rules was designed to find 'clusters' of TSSs. A 'clus-
tering score' was calculated by adding up contributions
from each TSS in a sliding window, weighting the differ-
ent reliability of TSSs from different sources and the dis-
tance of data points from the central window position.
The peaks of the resulting clustering score function were
regarded as potential 'virtual TSSs' for windows with
enough evidence points. In cases of genes with only few
data points the 5' most data point was used as 'virtual
TSS'. This collection of 'virtual TSSs' is the basis for the
extraction of promoter sequences.
Association between promoters and signal transduction 
pathways
TRANSPATH® [14] is a manually curated database focus-
ing on signal transduction pathways. Relevant elements
such as ligands, receptors, enzymes as well as TFs are
stored along with information about interactions, modifi-
cations, and other reactions they undergo. Chains are
sequences of reactions described in at least one paper, and
several chains may constitute a pathway. There are 24441
promoters for 14283 human genes documented in
TRANSPRO® 3.1, of them 1049 genes are associated with
a pathway or reaction chain described in TRANSPATH®
7.1 [14]. These 1049 promoter regions -1000 to +100 rel-
ative to TSSs calculated in TRANSPATH® were taken as a
primary data source. The promoters are associated with
Evaluation of significance of Elk-1 sites overrepresentation Figure 5
Evaluation of significance of Elk-1 sites overrepresen-
tation. Histogram of the ratio between Elk-1 site frequency 
in two sets of promoters randomly chosen from 
TRANSPRO® database. (100 times: 65 promoters in one set 
and 990 promoters in another set). The site frequency ratio 
2.1 observed in the real set of promoters from T-cell antigen 
receptor pathway is 3.9 SD away from the mean of the distri-
bution.
Real dataset ratio 
2.1 
3.9 SDBMC Bioinformatics 2006, 7(Suppl 2):S13
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360 pathways or chains, provided that at least 5 promot-
ers were associated with each pathway.
Identification of putative TFBS
TRANSFAC®  10.1 provides, among other information,
more than 8000 TFs, of them 1555 human TFs, as well as
a library of 795 PWMs including 569 matrices for verte-
brate TFs [1].
The program Match™ [17] was used to identify putative
binding sites in the promoters of each pathway or chain,
using the vertebrate PWMs. A built-in matrix profile with
Search for key TFs in T-cell antigen receptor pathway Figure 6
Search for key TFs in T-cell antigen receptor pathway. Automatically constructed diagram of the result of the search 
for key transcription factors. Starting from 12 molecules (out of 13) belonging to the T-cell antigen receptor pathway the 
search arrives at two TFs: NF-kappaB and c-Jun (AP-1) – known target TFs of this pathway.BMC Bioinformatics 2006, 7(Suppl 2):S13
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cut-off values adjusted to minimize the sum of false posi-
tive and false negative errors (minSUM) was used in the
detection of the sites.
F-Match: Identification of over- and under-represented 
sites in promoter sequences
In order to identify TFBS overrepresented in the promoter
sets, a control set was derived for each pathway or reaction
chain; the complete data source was taken excluding only
the promoters of the genes in the pathway being investi-
gated. The Match™ program was used to identify TF bind-
ing sites in this control collection and the number of sites
was taken as a background to compare with the number
of sites found in the promoters from the pathway in ques-
tion.
We have developed a new program, F-Match, which com-
pares the number of sites found in a query sequence set
against the control set. We assume, if a certain TF (or fac-
tor family), alone or as a part of a cis-regulatory module,
plays a significant role in the regulation of the considered
set of promoters, then the frequency of the corresponding
sites found in these sequences should be significantly
higher than expected by random chance. Often, the strin-
gency of the interaction of this TF with their target
sequences in the considered promoters is not known lead-
ing to the uncertainty in setting thresholds on the site
searches using the Match™ program.
F-Match carefully evaluates the set of promoters and for
each matrix tries to find two thresholds: one, th-max,
which provides maximum ratio between the frequency of
matches in the promoters in focus (set A) and background
promoters (set B) (over-represented sites); and the second
threshold, th-min, that minimizes the same ratio (under-
represented sites).
In order to find these two thresholds, first, we apply the
Match™ program to both sets of promoters using the low-
est PWM thresholds corresponding to the minimum of
false negative rates (minFN, see [17] for details). As a
result, for each PWM we obtain a set of predicted K sites
and M sites in the promoter sets A and B with the corre-
sponding matrix scores ms:
msA,1, msA,2, ... msA,K;
Table 2: Over and under-represented sites in in TNFα expression data. Predicted sites that are significantly over-represented (Ratio 
[FC>2.0] > 1.4) and under-represented (Ratio [FC>2.0] < 0.7) in the promoters of genes that are differentially expressed in primary 
human endothelial cells upon TNFα stimulation
Matrix ID in TRANSFAC® Ratio [FC>2.0] #sites k #sites m p-value Ratio [FC>2.5] Ratio [FC>3.0]
V$NFKAPPAB65_01 5.54 36 7 1.45·10-6 10.44 12.49
V$CREL_01 3.29 58 19 1.04·10-6 4.83 5.52
V$CDX2_Q5 2.45 41 18 7.35·10-4 2.90 2.74
V$IRF_Q6 1.88 68 39 9.46·10-4 --
V$AP1_01 2.09 35 18 6.51·10-3 2.55 2.78
V$FOXJ2_02 1.58 94 64 2.70·10-3 1.61 1.78
V$MAZ_Q6 1.45 284 211 2.32·10-5 --
V$GATA4_Q3 1.58 139 95 3.50·10-4 2.54 2.69
V$CETS1P54_01 0.20 63 2 3 . 1 9 · 1 0 -5 0.38 0.50
V$YY1_02 0.30 12 43 5.21·10-5 0.25 -
V$USF_02 0.38 18 50 2.15·10-4 0.36 0.39
V$CREBATF_Q6 0.61 65 114 9.35·10-4 --
V$E2F_Q3_01 0.63 88 149 4.13·10-4 0.36 0.28
V$MYC_Q2 0.64 87 145 7.05·10-4 0.45 0.50
k and m – numbers of sites computed in A and B sets respectively. p-value is computed according to the eq. 2.
The results of the simulation experiments Figure 7
The results of the simulation experiments. Depend-
ence of the sensitivity and specificity levels on the key node 
search parameters: d-distance, and h-pathway persistence. 
Usage of high values of persistence parameter h allows reach-
ing sensitivity levels above 50% without significant decrease 
of specificity.
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msB,1, msB,2, ... msB,M.
The F-Match program makes an exhaustive search through
the space of all scores observed in the sequence sets. Each
observed score is taken as a threshold th and the program
computes the number of sites k found in the promoter set
A (msA,j ≥ th/j = 1,K) and number of sites m found in the
promoter set B (msB,j ≥ th/j = 1,M).
Then, the expected number of sites in the set A to be
observed in the case of even distribution of sites between
two sets will be:
and assuming a binomial distribution of the sites between
two sets we can calculate the p-value of finding the
observed number of sites and higher, for over-represented
matches, or lower, in the case of under-represented
matches
giving the p-value of over- and under-representation of
matches in the promoter set A.
For a given significance level ξ (e.g. ξ = 0.001) the F-Match
finds such thresholds th-max and th-min that maximizes
and minimizes, respectively, the ratio k/kexp provided that
the p-value <ξ. If the required significance level cannot be
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Table 3: Key transcription factors found by pathway analysis of TNFα expression data. Transcription factors found by the downstream 
key node search starting from 129 signal pathway molecules whose expression has been changed more than 2-fold in primary human 
endothelial cells upon TNFα stimulation. (requires some explanation of the parameters shown here) Ni - number od relevant 
reachable molecules from the key node; Mi - number of non-relevant reachable molecules from the key node; Si - specifically score 
(see equation (3)).
TRANSPATH® molecule acc TF name Ni Mi si
MO000018096 MEF-2C 80 1520 67.48
MO000020766 MEF-2° 71 557 66.48
MO000020759 NF-AT2 82 2040 65.65
MO000016887 STAT1alpha 89 2920 65.61
MO000000279 c-Fos 83 2202 65.42
MO000017496 FOXO3 74 1292 63.92
MO000013133 STAT5B 84 2578 63.89
MO000033504 PPAR-alpha 73 1218 63.55
MO000013122 STAT3 94 3946 63.44
MO000037096 MITF 78 1955 62.97
MO000019430 ER 72 1357 61.77
MO000017189 CREB 86 3223 61.72
MO000000038 Elk-1 80 2427 61.72
MO000038332 IkappaB-alpha, IkappaB-beta 87 3562 60.64
MO000045008 FOXO3, FOXO4 78 2350 60.61
MO000017212 NF-AT 82 2906 60.53
MO000044995 FOXO 78 2370 60.5
MO000013119 STAT1 87 3600 60.44
MO000022492 PPAR-gamma 77 2269 60.3
MO000017515 E2F 72 1638 60
MO000013126 STAT5A 82 3035 59.83
MO000000062 ATF-2 73 1818 59.74
MO000016628 SAP-1 77 2407 59.51
MO000000059 SRF 80 2885 59.16
MO000016876 STAT5 84 3521 58.75
MO000018995 RXR-alpha 77 2551 58.72
MO000034151 HIF-1alpha 78 2762 58.33
MO000045358 YY1:p53 71 1879 57.75
MO000017658 Smad2 82 3513 57.39
MO000000049 c-Jun 82 3622 56.86
MO000000058 NF-kappaB 77 3132 55.7BMC Bioinformatics 2006, 7(Suppl 2):S13
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reached for a given matrix, then the program reports that
no optimal threshold can be found.
Identification of key nodes in signal transduction networks
To understand the mechanisms of gene expression, micro-
array data should be analysed in the context of complex
regulatory networks of a cell. Through such networks, dif-
ferent signals can converge to few key TFs involved in reg-
ulation of the large gene sets. We have developed a tool,
integrated in the ExPlain™ computer system, that allows
fast search for key transcription factors regulated by a sig-
nal transduction network. A network is defined as
weighted graph G = (V, E, C), where V = genes ∪ molecules
is the set of vertices, E = reactions are the edges and C : E →
R+ ∪{0} is the cost function that defines a non-negative
value for every edge. In the simplest variant of the algo-
rithm, the initial values of the cost functions for each
direct reaction are taken = 1.0. So, the cost of any path
through the consequent reactions will be equal to the
number of reactions.
Dijkstra's shortest-path algorithm is the core of this
approach. The algorithm of downstream search starts
from each molecule of the set of molecules in focus (sub-
set Vx of V) (e.g. signalling molecules whose expression
has changed in the microarray experiment) and construct
the shortest-path to all nodes i of V being within a given
radius of dmax. After evaluating all nodes of Vx the algo-
rithm calculates the number of visits Ni for each node i of
V. This corresponds to the number of molecules in focus
that can transfer the signal to the node i  within dmax
number of steps. The values Ni could already be used as a
ranking score for potential key nodes, since Ni  corre-
sponds to the number of differentially expressed mole-
cules from the initial list Vx that can transfer the signal to
the node i. In the case that node i represents a transcrip-
tion factor and is characterized by a high Ni, then this tran-
scription factor seems the most probable target and key
regulator of the signal transduction system under study.
In order to calculate the "specificity score" we use the for-
mula:
si = Ni/(1 + αMi)   (3)
where  Mi is the number of all other molecules in the
whole network, which can reach node i within dmax and
which are considered as "non-relevant nodes". By setting
different penalty levels (α = [0,1]) user has an opportunity
to adjust the balance between true positives and false pos-
itives while searching for the key nodes. In the Web imple-
mentation of the algorithm we offer 21 penalty levels that
correspond to:
The values Mi are pre-calculated for every node and radius.
Pathway Persistence algorithm
In addition to the information about individual reactions
TRANSPATH® contains information about pathways and
chains of consecutive reactions known to take place in cer-
tain cellular conditions. Any pathway P is defined by a
graph GP = (VP, EP, C) which is a sub-graph of the graph G.
We use the information about chains and pathways to
improve the accuracy of key node prediction, especially to
diminish the false positive error. While searching, the pri-
ority is given to the potential paths that utilize annotated
chains of reactions. Still, predictions beyond the known
paths are allowed but with low priority.
Application of pathway information into a certain graph
can be transparently modeled by introduction of addi-
tional transitive edges with specific costs, which results in
a new graph G'. The pathway information is fully repre-
sented by these additional edges. The main Dijkstra algo-
rithm remains unchanged in this model. The additional
edges for one pathway P are generated as follows: Let SPij
be the graph of the shortest paths between i,j ∈ VP within
the graph (e.g. pathway) P. Further, let CPij be the cost of
the shortest path with the exceptional case where CPij = ∞
if SPij = ∅. We combine GP and G yielding G' = (V,E',C')
simply by introducing new edges E' = E∪{(i,j) | SPij ≠ ∅}
and by extending the cost function for them by C'  =
{f(CPij) | f(CPij)≤Cij}∪{Cij|f(CPij)>Cij}. As function f  we
use f(x) = x(1-h), with h∈ [0,1]. The aim of f is to make the
cost function of a new edge (i, j) sublinearly dependent on
the length of the corresponding shortest path SPij within
each pathway. As a result, with increasing h the shortest-
path search is progressively pushed to stay within known
pathways (see Figure 1). This affects the search of the key
nodes. The effect is maximal if h = 1 and absent if h = 0.
Therefore we call h "pathway persistence" which allows
the user to select the proper balance between making
speculative predictions or staying within known pathways
only. This approach is inspired by Higher-Order-Markov-
Chains, where subsequent past states define the probabil-
ity of the future states of a stochastic system.
Duplicated edges can occur due to pathway overlapping.
We merge them to one edge by combining their costs syn-
ergistically. The cost of the merged edge is calculated from
the individual costs ci by
α = () 0
1
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While the search for common key nodes is already easily
possible by application of Dijkstra to G', the connection
details between a certain identified key node and starting
nodes are not yet obvious, since they are established in G',
not in G. Therefore, we implemented a sophisticated
dynamic cost function which still can be used by Dijkstra,
and which mimics the existence of edges E' on-the-fly,
while the shortest-paths themselves consist of edges from
E only.
List of abbreviations
TFs – transcription factors
HMMs – Hidden Markov Models
PWMs – positional weight matrices
TFBS – transcription factor binding sites
TSSs – transcription start sites
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